Jude Onyia

Technik-/Wissenschafts-/F&E-Leiter bei NEUROCRINE BIOSCIENCES, INC.

Vermögen: 2 Mio $ am 30.04.2024

60 Jahre

Health Technology

Consumer Services

Commercial Services

Aktive Positionen von Jude Onyia

Unternehmen	Position	Beginn	Ende
NEUROCRINE BIOSCIENCES, INC.	Technik-/Wissenschafts-/F&E-Leiter	30.11.2021	-
VOYAGER THERAPEUTICS, INC.	Direktor/Vorstandsmitglied	21.02.2023	-

Unternehmen	Position	Beginn	Ende
Capsida Biotherapeutics, Inc. Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA.	Technik-/Wissenschafts-/F&E-Leiter	01.06.2021	01.11.2021
ELI LILLY AND COMPANY	Corporate Officer/Principal	01.09.2014	01.06.2021

The State University of New York	Undergraduate Degree
State University of New York at Downstate Medical Center	Doctorate Degree

International

Vereinigte Staaten

Operativ

Chief Tech/Sci/R&D Officer	2
Undergraduate Degree	1
Corporate Officer/Principal	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
NEUROCRINE BIOSCIENCES, INC.	Health Technology
ELI LILLY AND COMPANY	Health Technology
VOYAGER THERAPEUTICS, INC.	Health Technology

Private Unternehmen	1
Capsida Biotherapeutics, Inc. Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA.	Commercial Services